TD Cowen analyst Andrew Sherman raised the firm’s price target on Axon (AXON) to $725 from $700 and keeps a Buy rating on the shares. The firm ...

Septerna was launched by preeminent drug discovery company builders and scientific leaders in the biochemistry, structural biology, and pharmacology of GPCRs. For more information, please visit ...

IN8bio, Inc. (Nasdaq: INAB), a leading clinical-stage biopharmaceutical company focused on innovative gamma-delta T cell ...

KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and ...

Warren Buffett has always critiqued airline stocks for being overly capital-intensive, exhibiting low growth, and relying ...

In a report released today, Andrew Kligerman from TD Cowen maintained a Hold rating on Skyward Specialty Insurance Group, Inc. (SKWD – Research ...

Biodesix is a leading diagnostic solutions company with five Medicare-covered tests available for pulmonology patients. The ...

Unilever’s revelation of the departure of Hein Schumacher – before he could celebrate a second summer as CEO – was shrouded ...

Nvidia must meet its “normal exceed” of Wall Street expectations to keep its stock price elevated, said an analyst.

AI stocks in Europe fell over the last few days after TD Cowen said Microsoft canceled some leases for the buildout of its US ...

The report raised fears about the sustainability of AI infrastructure growth. That could mean less demand for Nvidia’s chips.

Microsoft's data center lease cancellation raises questions about the industry's staggering growth. Experts say the market ...